Skip to main content

Table 1 Patient characteristics and PET data

From: Comparison of 4′-[methyl-11C]thiothymidine (11C-4DST) and 3′-deoxy-3′-[18F]fluorothymidine (18F-FLT) PET/CT in human brain glioma imaging

Case no. Age (years)/sex Tumor type a Primary/recurrence Ki-67 index 4DST FLT
SUVmax T/N ratio SUVmax T/N ratio
1 64/F DA Primary 1 0.53 1.71 0.57 2.71
2 22/M DA Primary 5 0.53 1.51 0.28 1.75
3 46/M AA Primary 15 0.85 2.24 0.95 5.59
4 73/M AA Primary 20 2.35 6.91 2.41 14.18
5 64/M AOA Primary 85 1.13 3.77 1.06 7.57
6 69/F GBM Primary 20 1.63 4.66 1.34 6.70
7 39/F GBM Primary 70 1.44 4.80 1.72 7.82
8 76/F GBM Primary 90 6.95 18.29 3.23 17.95
9 72/F GBM-O Primary 70 1.57 4.76 1.35 7.11
10 34/M AA Recurrence 22 2.24 9.33 1.88 14.46
11 73/M AOA Recurrence 80 2.67 8.34 4.68 20.35
12 47/F AOA Recurrence 35 1.52 4.34 1.78 7.74
13 52/M GBM Recurrence 15 2.80 6.09 2.56 15.06
14 46/M GBM Recurrence 35 3.50 10.94 3.52 15.30
15 29/F GBM Recurrence 50 1.56 6.50 1.52 13.82
16 46/M GBM Recurrence 70 3.11 8.64 3.12 18.35
17 29/F GBM Recurrence 60 1.22 4.69 1.95 13.93
16 79/F GBM Recurrence 40 1.90 4.63 1.94 7.46
19 69/M GBM Recurrence 5 1.52 4.47 1.45 8.06
20 29/F GBM-O Recurrence 20 1.10 2.50 1.38 5.11
  1. aDA: diffuse astrocytoma, AA: anaplastic astrocytoma, AOA: anaplastic oligoastrocytoma, GBM: glioblastoma, GBM-O: glioblastoma with oligodendroglioma component. 4DST: 4′-thiothymidine, FLT: fluorothymidine, SUVmax: maximum standardized uptake value, T/N ratio: tumor-to-normal tissue uptake ratio.